Regencell Bioscience Holdings (RGC) Income Statement

Click line-items for a historical chart and %

Admissions	525.3M
Concessions	239.9M
Other operating revenues	46.3M
TOTAL REVENUES	811.5M
Film rental and advertising costs	275.6M
Cost of concessions	31.3M
Rent expense	107.3M
Other operating expenses	226.3M
General and administrative expenses (including share-based compensation of $2.2 and $2.1 for the quarters ended June 30, 2011 and July 1, 2010, and $4.1 and $3.6 for the two quarters ended June 30, 2011 and July 1, 2010, respectively)	20.5M
Depreciation and amortization	58.5M
Net loss on disposal and impairment of operating assets
TOTAL OPERATING EXPENSES	724.3M
INCOME FROM OPERATIONS	87.2M
Interest expense, net	31.9M
Loss on extinguishment of debt	0
Earnings recognized from NCM	-3.6M
Other, net
TOTAL OTHER EXPENSE (INCOME), NET	15.7M
INCOME BEFORE INCOME TAXES	71.5M
PROVISION FOR INCOME TAXES	29.2M
NET INCOME	42.3M
NONCONTROLLING INTEREST, NET OF TAX	0
NET INCOME ATTRIBUTABLE TO CONTROLLING INTEREST	42.3M
Basic (in dollars per share)	0.27
Diluted (in dollars per share)	0.27
Basic (in shares)	156.02M
Diluted (in shares)	156.86M
Dividends declared per common share (in dollars per share)	0.22

Entities mentioned with RGC

View All Entities